Chondroitin Sulfate Market Size, Share, Growth Analysis, By Source(Bovine, Swine), By Application(Nutraceuticals, Pharmaceuticals) - Industry Forecast 2024-2031

Chondroitin Sulfate Market size was valued at USD 1.21 Billion in 2021 and is poised to grow from USD 1.25 Billion in 2022 to USD 1.65 Billion by 2030, at a CAGR of 3.5 % during the forecast period (2023-2030).

The chondroitin sulfate market is fragmented in nature because there are so many manufacturers, particularly in China. There is fierce competition in the sector as a result of the increased R&D expenditures for resource innovation and enhancing source efficiency. High levels of pricing competition among sources and companies' shifting focus towards increasing use of organic extracts are signs of intense competition. The primary areas that are important for manufacturers are the sourcing of sustainable raw materials and efficient sourcing strategies. Companies are using cartilage having a high purity concentration to create the sources. For instance, ZPD offers various grades that include sodium chondroitin sulfate in amounts of 20%, 40%, and 80%, as well as additional varieties of sodium chondroitin sulfate ingredients that are compliant with rules for pet food producers. 'Synutra Ingredients', 'TSI Group Ltd.', 'Bioiberica', 'Seikagaku Corporation', 'Shandong Runxin Biotechnology Co., Ltd.', 'Jiaxing Hengjie Biopharmaceutical Co., Ltd.', 'Summit Nutritionals International Inc.', 'Bio-gen Extracts Pvt. Ltd.', 'Yantai Dongcheng Pharmaceutical Group Co., Ltd.', 'Sioux Pharm, Inc.', 'Pacific Rainbow International, Inc.', 'ZPD A/S', 'Bausch Health Companies Inc.', 'Jiaxing Yueteng Biological Technology Co., Ltd.', 'San Xinyuan Food Industry Co., Ltd.', 'Zeria Pharmaceutical Co., Ltd.', 'YBCC (Yantai BeiYang Chemtech Co., Ltd.)', 'Marcor Development Corporation', 'Huiwen Pharmaceutical (Shandong) Co., Ltd.', 'Qingdao Green-Extract Biology Science and Technology Co., Ltd.'

As the population continues to age, there is a higher incidence of joint-related ailments such as osteoarthritis. Chondroitin sulfate is commonly used in the treatment of osteoarthritis as it helps in reducing pain, inflammation, and improving joint function. The aging population is a significant driver for the chondroitin sulfate market.

Increasing Demand for Natural and Organic Ingredients: There is a growing preference among consumers for natural and organic products, including supplements and nutraceuticals. This trend has led to an increased demand for chondroitin sulfate derived from natural sources such as bovine, porcine, and marine origins. Manufacturers are focusing on offering chondroitin sulfate products that meet these consumer preferences.

North America dominated the market with a 36.2% revenue share in 2022. This is attributable to the FDA's approval of the use of goods including sodium chondroitin sulfate as well as the expansion of the American pharmaceutical sector. Demand is also expected to be fueled by factors including the rising prevalence of osteoarthritis, rising use of cholesterol medication, cataract surgery, or formulations for eye drops. A few companies in Europe use chondroitin sulfate, but those that do include those in the pharmaceutical, cosmetics, food, animal feed, and veterinary fields. In dietary supplements, chondroitin sulfate is a substitute medicine used to treat osteoarthritis.